Results 51 to 60 of about 14,464 (157)
Pharmacology Research &Perspectives, Volume 9, Issue 2, April 2021., 2021 Higher concentrations of anti‐VEGF agents have been observed after ocular administration of nanoparticulate systems in the long‐term in comparison to those of solution formulations of the same agents. The improvements on therapy offered by these nanoparticulate systems have also been evidenced in the higher antiangiogenic properties reported in in ...
María L. Formica +2 more
wiley +1 more source
Erratum to "Osteonecrosis of the jaw associated with ziv-aflibercept". [PDF]
J Gastrointest Oncol, 2017 europepmc +3 more sources
Clinical Case Reports, Volume 9, Issue 1, Page 61-66, January 2021., 2021 Association of immunotherapy and/or chemotherapy and/or targeted therapy, in sequence or as single therapies, may induce osteonecrosis of the jaw. Multidisciplinary team management of these patients should be provided. Abstract Association of immunotherapy and/or chemotherapy and/or targeted therapy, in sequence or as single therapies, may induce ...
Agostino Guida +4 more
wiley +1 more source
Intravitreal Therapy for Diabetic Macular Edema: An Update
Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021 Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight‐threatening condition, it is also among the most accessible to treatment. Many different treatment options including photocoagulation, intravitreal medical treatment (either vascular endothelial growth factor inhibitors or ...
Claudio Furino +4 more
wiley +1 more source
Drug Monographs: Ziv-aflibercept and Vincristine Sulfate Liposome [PDF]
Hospital Pharmacy, 2013 The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.
Jessica N, Lee +2 more
openaire +2 more sources
pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
International Journal of Retina and Vitreous, 2017 Background The aim of the study was to measure pH changes of the human vitreous caused by the intravitreal drugs bevacizumab, ranibizumab, aflibercept, and ziv-aflibercept.
Bianka Sobolewska +3 more
doaj +1 more source
Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts. [PDF]
PLoS ONE, 2014 The Notch ligand Delta-like 4 (Dll4) is highly expressed in vascular endothelium and has been shown to play a pivotal role in regulating tumor angiogenesis.
Kiersten Marie Miles +12 more
doaj +1 more source
NCI 8628: A randomized phase 2 study of ziv‐aflibercept and high‐dose interleukin 2 or high‐dose interleukin 2 alone for inoperable stage III or IV melanoma [PDF]
Cancer, 2018 Ahmad A Tarhini +2 more
exaly +2 more sources
Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture [PDF]
, 2014 PurposeTo compare the safety profiles of antivascular endothelial growth factor (VEGF) drugs ranibizumab, bevacizumab, aflibercept and ziv-aflibercept on retinal pigment epithelium cells in culture.MethodsHuman retinal pigment epithelium cells (ARPE-19 ...
Kuppermann, Baruch D +6 more
core +1 more source